Skip to main content Accessibility help
×
Home

Multidrug-Resistant Gram-Negative Pathogens Multiple Approaches and Measures for Prevention

  • Jan E. Patterson (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Multidrug-Resistant Gram-Negative Pathogens Multiple Approaches and Measures for Prevention
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Multidrug-Resistant Gram-Negative Pathogens Multiple Approaches and Measures for Prevention
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Multidrug-Resistant Gram-Negative Pathogens Multiple Approaches and Measures for Prevention
      Available formats
      ×

Abstract

Copyright

Corresponding author

South Texas Veterans Health Care System, San Antonio, TX 78229, (pattersonj@uthscsa.edu)

References

Hide All
1.Gardiner, DF, Scholand, SJ, Babinchak, . Mortality and gram-negative rod bacteremia in the intensive care unit. J Hosp Infect 2006; 62:453457.
2.Friedman, G, Sliva, E, Vincent, JL. Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:20782080.
3.Lautenbach, E, Weiner, MG, Nachamkin, I, Bilker, WB, Sheridan, A, Fishman, NO. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006; 27 893900 (in this issue).
4.Fortaleza, CMCB, Freire, MP, Moreira Filho, DC, Carvalho Ramos, M. Risk factors for recovery of imipenem- or ceftazidime-resistant Pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil. Infect Control Hosp Epidemiol 2006; 27 901906 (in this issue).
5.Harris, AD, Karchmer, TB, Carmeli, Y, Samore, MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001; 32:10551061.
6.Kaye, KS, Harris, AD, Samore, M, Carmeli, Y. The case-case-control study design: addressing the limitation of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005; 26:346351.
7.Harris, AD, Smith, D, Johnson, JA, Bradham, DD, Roghmann, MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002; 34:340345.
8.Troillet, N, Samore, MH, Carmeli, Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 1997; 25:10941098.
9.Gales, AC, Menezes, LC, Silbert, S, Sader, HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Antimicrob Chemother 2003; 52:699702.
10.Aubert, G, Pozzetto, B, Dorche, G. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. J Antimicrob Chemother 1992; 29:307312.
11.Kollef, MH, Sherman, G, Ward, S, Fraser, VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462474.
12.Marra, AR, Pereira, CAP, Gales, AC, et al. Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother 2006; 50:388390.
13.Kang, CI, Kim, SH, Park, WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49:760766.
14.Gomes, CC, Vormittag, E, Santos, CR, Levin, AS. Nosocomial infection with cephalosporin-resistant Klebsiella pneumoniae is not associated with increased mortality. Infect Control Hosp Epidemiol 2006; 27 907912 (in this issue).
15.Ibrahim, EH, Sherman, G, Ward, S, Fraser, VJ, Kollef, MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146155.
16.Hyle, EP, Lipworth, AD, Zaoutis, TE, Nachamkin, I, Bilker, WB, Lautenbach, E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. Arch Intern Med 2005; 165:13751380.
17.Ramphal, R, Ambrose, PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 2006; 42(Suppl 4):S164S172.
18.Harbarth, S, Garbino, J, Pugin, J, Romand, JA, Lew, D, Pittet, D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529535.
19.Bates, DW, Pruess, KE, Lee, TH. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med 1995; 155:593598.
20.Dupont, H, Montravers, P, Gauzit, R, et al. Outcome of postoperative pneumonia in the EOLE study. Intensive Care Med 2003; 29:179188.
21.Paterson, DL, Ko, WC, Von Gottberg, A, et al. Outcome of cephalosporin treatment serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001; 39:22062212.
22.Andes, D, Craig, WA. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. Clin Microbiol Infect 2005; 11(Suppl 6):1017.
23.Gunale, A, von Baum, P, Wendt, C. Survival of cephalosporin-resistant Enterobacteriaceae on fingers. Infect Control Hosp Epidemiol 2006; 27: 974977 (in this issue).

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed